United States · Series A startup

Who invested in DNA Response

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$3.6Mraised across 2 rounds since 2011, from 2 sources

$575KSeed$3.0MSeries A
Latest round
Series A, $3.0MFeb 2012
Step-upi
5.2×
Investors
4
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2012
$575KSeed$3.0MSeries A
First round
Seed, $575K
Jun 2011
Biggest round
$3.0M
Series A · Feb 2012
Between rounds
8 months
from the last two

The rounds

  1. Feb 2012
    Series A$3.0M3 new1 returning

    Reported by geekwire.comSEC filing: $1.6M sold, first sale Feb 2012

  2. Jun 2011
    Seed$575K1 new

    Reported by geekwire.com

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Benaroya CapitalVC firm2rounds
Geoff EntressVC firm1round
iSherpa CapitalInvestment firm1round
Mark DiSalleAngel1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about DNA Response

Who invested in DNA Response?

DNA Response's investors include Benaroya Capital, Geoff Entress, iSherpa Capital and Mark DiSalle.

How much has DNA Response raised?

DNA Response has raised $3.6M across 2 rounds since 2011.

When did DNA Response last raise?

DNA Response's most recent round was a Series A of $3.0M in Feb 2012.

What was DNA Response's biggest round?

Its most recent round, $3.0M in Feb 2012, is also its largest on record.

Who backed DNA Response first?

DNA Response's first round on record, in Jun 2011, was backed by Benaroya Capital.

What stage is DNA Response at?

DNA Response's latest named round is a Series A, in Feb 2012.

Where is DNA Response based?

DNA Response is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.